NCT02176655View on ClinicalTrials.gov

Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Delayed Alcohol Induced Headache
Interventions
DRUG

VVD-101

All subjects will treat 6 headaches with either VVD-101 or placebo in a randomized order.

DRUG

Placebo

All subjects will treat 6 headaches with either VVD-101 or placebo in a randomized order.

Trial Locations (2)

65807

Clinvest, Springfield

94040

South Drive Medical Clinic, Mountain View

All Listed Sponsors
collaborator

Vivid Pharma Inc.

INDUSTRY

lead

Cady, Roger, M.D.

INDIV

NCT02176655 - Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches | Biotech Hunter | Biotech Hunter